Cargando…

Chromenones as Multineurotargeting Inhibitors of Human Enzymes

[Image: see text] The complex nature of multifactorial diseases, such as Morbus Alzheimer, has produced a strong need to design multitarget-directed ligands to address the involved complementary pathways. We performed a purposive structural modification of a tetratarget small-molecule, that is conti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemke, Carina, Christmann, Joscha, Yin, Jiafei, Alonso, José M., Serrano, Estefanía, Chioua, Mourad, Ismaili, Lhassane, Martínez-Grau, María Angeles, Beadle, Christopher D., Vetman, Tatiana, Dato, Florian M., Bartz, Ulrike, Elsinghorst, Paul W., Pietsch, Markus, Müller, Christa E., Iriepa, Isabel, Wille, Timo, Marco-Contelles, José, Gütschow, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933783/ https://www.ncbi.nlm.nih.gov/pubmed/31891098 http://dx.doi.org/10.1021/acsomega.9b03409

Ejemplares similares

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2020)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy
por: Zribi, Lazhar, et al.
Publicado: (2020)

Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties
por: Diez-Iriepa, Daniel, et al.
Publicado: (2020)

Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer’s Disease
por: Alonso, José M., et al.
Publicado: (2021)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
por: Pachón-Angona, Irene, et al.
Publicado: (2019)

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
por: Ramos, Eva, et al.
Publicado: (2019)

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
por: Dgachi, Youssef, et al.
Publicado: (2016)

Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives
por: Pachón Angona, Irene, et al.
Publicado: (2020)

Synthesis of 2H-Chromenones from Salicylaldehydes and Arylacetonitriles
por: Li, Chengcai, et al.
Publicado: (2017)

Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids
por: Bautista-Aguilera, Oscar M, et al.
Publicado: (2014)

Synthesis, Neuroprotection, and Antioxidant Activity of 1,1′-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models
por: Chamorro, Beatriz, et al.
Publicado: (2021)

Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
por: Dakhlaoui, Imen, et al.
Publicado: (2023)

Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models
por: Chamorro, Beatriz, et al.
Publicado: (2020)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
por: Choura, Emna, et al.
Publicado: (2022)

Synthesis of Novel Tricyclic Chromenone-Based Inhibitors of IRE-1 RNase Activity
por: Ranatunga, Sujeewa, et al.
Publicado: (2014)

6-exo-trig Michael addition-lactonizations for catalytic enantioselective chromenone synthesis
por: Neyyappadath, Rifahath M., et al.
Publicado: (2017)

Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders
por: Dhiman, Priyanka, et al.
Publicado: (2019)

Drug like HSP27 cross linkers with chromenone structure ameliorates pulmonary fibrosis
por: Yoo, Young Jo, et al.
Publicado: (2023)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

Synthesis and Antioxidant Properties of HeteroBisNitrones Derived from Benzene Dicarbaldehydes
por: Diez-Iriepa, Daniel, et al.
Publicado: (2022)

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
por: Marco-Contelles, José, et al.
Publicado: (2016)

Exploration of the Fluorescent Properties and the Modulated Activities against Sirtuin Fluorogenic Assays of Chromenone-Derived Natural Products
por: Wen, Hui, et al.
Publicado: (2018)

Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
por: Chamorro, Beatriz, et al.
Publicado: (2023)

Rabenchromenone and Rabenzophenone, Phytotoxic Tetrasubstituted Chromenone and Hexasubstituted Benzophenone Constituents Produced by the Oak-Decline-Associated Fungus Fimetariella rabenhorstii
por: Bashiri, Samaneh, et al.
Publicado: (2020)

Chromenone Derivatives as Monoamine Oxidase Inhibitors from Marine-Derived MAR4 Clade Streptomyces sp. CNQ-031
por: Oh, Jong Min, et al.
Publicado: (2021)

Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels
por: Pachòn Angona, Irene, et al.
Publicado: (2020)

Postischemic Neuroprotection of Aminoethoxydiphenyl Borate Associates Shortening of Peri-Infarct Depolarizations
por: Fernández-Serra, Rocío, et al.
Publicado: (2022)

Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
por: Karimi Askarani, Hajar, et al.
Publicado: (2020)

Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
por: Malek, Rim, et al.
Publicado: (2022)

Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models
por: Chamorro, Beatriz, et al.
Publicado: (2023)

Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke
por: Martínez-Alonso, Emma, et al.
Publicado: (2020)

Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment
por: Diez-Iriepa, Daniel, et al.
Publicado: (2022)

N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2022)

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy
por: Rodríguez-Ruiz, Emelina R., et al.
Publicado: (2023)

Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke
por: Martínez-Alonso, Emma, et al.
Publicado: (2022)

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
por: Knez, Damijan, et al.
Publicado: (2023)

Pharmacophore Modelling and Synthesis of Quinoline-3-Carbohydrazide as Antioxidants
por: El Bakkali, Mustapha, et al.
Publicado: (2011)

In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases
por: Więckowska, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ruatdcb9k4u3u1skja1bm3lnb